Santa Cruz Good Times

Tuesday
Aug 04th
Text size
  • Increase font size
  • Default font size
  • Decrease font size

Historic Shift in Drug Research

news marijuanaSanta Cruz nonprofit MAPS could complete the first study of therapeutic whole-plant marijuana in 40 years

While stacks of independent research have affirmed the medicinal potentials of the cannabis plant, none received the official approval of the U.S. government. But soon we could be looking at the first federally sanctioned research to take place on marijuana in 40 years, outside of limited research by government organizations.

On March 14, marking a historic shift in U.S. drug policy, the Public Health Service (PHS) approved the protocols for a study of cannabis’ effects on 12 treatment-resistant combat veterans with Post Traumatic Stress Disorder (PTSD). The study is sponsored by the Santa Cruz-based Multidisciplinary Association for Psychedelic Studies (MAPS) and its protocols were already approved by the U.S. Food and Drug Administration (FDA) three years ago. They were also approved by the University of Arizona Institutional Review Board (IRB), and the University of Arizona has agreed to play host with psychiatrist and MD Sue Sisley as principal investigator.

MAPS has tried for more than 14 years to complete a federally sanctioned clinical research study of marijuana. So far, the National Institute on Drug Abuse (NIDA), which has a DEA-protected monopoly on the only legal supply of marijuana that can be used for FDA-regulated research, has refused to sell them cannabis. However, it seems that could be about to change.

A few years ago, Rick Doblin, executive director of MAPS, teamed up with Sisley to develop protocols for the PTSD study. In the United States, 22 veterans kill themselves per day according to statistics from the Department of Veterans Affairs, and often those suicides are related to PTSD symptoms. In recent years, more and more veterans have been speaking out about cannabis’ ability to mitigate PTSD. They say it doesn’t make them feel numb the way most prescription PTSD treatments do.

“This is a dire need, understanding PTSD, not just for combat vets but for all our citizens who are plagued by this,” Sisley said in a February article. “Any physician who’s also a human being can’t rest when we know that there’s something out there, in this case a plant, that has the potential to reduce human suffering.”

But while many vets are calling for increased access to marijuana medicine, the study in question would be the first-ever controlled, clinical study to look at using marijuana to treat PTSD in human patients.

Brad Burge, communications director for MAPS, notes that prior animal studies, among them a study using lab rats published in the scientific journal Nature, have shown that cannabis helps calm an overactive fear system.

Despite FDA approval, there was still a gaping problem until this month: In order to purchase NIDA weed, the PHS had to complete a third review process, as required by a 1999 guideline.

After the original study protocol was rejected by PHS in September 2011, MAPS resubmitted a revised protocol on Oct. 24, 2013. Then the line went dead for four months. Unlike FDA protocols, which require a response within 30 days, there is no timeline requiring PHS to respond. Finally, in the second week of March, PHS responded.

PHS approval matters because marijuana has more restrictions than any other illicit substance in the country. The federal government still lists it as a Schedule I substance—meaning a substance with “no currently accepted medical use and a high potential for abuse” according to the DEA. And, as required by the 1999 guideline, marijuana is the only Schedule I substance that requires an extra approval by the PHS, on top of FDA approval, before it can be studied. This makes pot the most difficult substance in the United States to research under federal law.

“If it can be shown that marijuana helps reduce depression and suicidality, which are things we want to explore in the study, then we can save a lot of lives,” says Burge, noting that the study would look at 50 vets, but would apply to anyone suffering from PTSD.

Burge notes that while the government does fund research and provide cannabis for some studies of isolated cannabinoids—for example looking just at THC or studies on synthetic cannabinoids—“they’re doing everything they can to prevent any form of research into the benefits of smoked, whole plant marijuana as a potential prescription medicine.”

While the PHS approval overcomes an enormous hurdle, MAPS still needs the DEA to sign off before it can purchase research-grade marijuana from NIDA. Then, the first government-approved, non-government study of marijuana in four decades can begin.

Comments (1)Add Comment
It's about time
written by Jason Porter Collinsworth, March 31, 2014
This is huge news for the medical marijuana industry. I'm glad they are finally focusing on marijuana instead of MDMA (ecstasy) or LSD.

Write comment
smaller | bigger

busy
 

Share this on your social networks

Bookmark and Share

Share this

Bookmark and Share

 

Health Screening

Santa Cruz wellness expert releases app to improve workplace well-being

 

Leo Sun; Full Moon, Venus Retro in Leo; Saturn Direct

It’s a complex week of planetary movements, challenges, demands and callings. We’re in the time of the Leo Sun. Leo—fixed fire, gold, the heart, generous, strong, noble, the king/queen—needs appreciation and praise from everyone in order to move forward. During Leo we gain a greater sense of self-identification by recognizing our creativity. It’s therefore a perfect time for Venus retrograding in Leo. In Venus retrograde we review and re-assess values. Venus retro in Leo concerns our self as valuable, acknowledging talents, gifts, abilities and offerings. Friday, Venus re-enters Leo (29 degrees, a critical degree) continuing the retrograde to 14 degrees Leo on Sept. 6. Friday (Full Moon) is also the (8 degrees) Leo solar festival, Festival of the Future. Leo is the heart of the sun, the heart of all that matters. When attuned to this heart, we have understanding and inclusivity. The heart of the Lion is Mitra (think “Maitreya,” the coming World Teacher). Leo prepares humanity to receive divine love from subtle sources and later to radiate that love to the kingdoms. Sirius, Ray 2, where love originates, streams through Regulus (heart of Leo), into the heart of the sun (Ray 2) and into all hearts. The heart of Leo is Regulus. Joining Venus, the love underlying all of creation appears. Saturday is Sun/Neptune (confusion or devotion) with late night Saturn turning stationary direct. Ideas, plans and structures held long in abeyance (since March 14) slowly move forward. (Read more on Leo and the week at nightlightnews.org and Risa D’Angeles’ Facebook page, accessed through my website.)

 

The New Tech Nexus

Community leaders in science and technology unite to form web-based networking program

 

Film, Times & Events: Week of July 31

Santa Cruz area movie theaters >
Sign up for Good Times weekly newsletter
Get the latest news, events

RSS Feed Burner

 Subscribe in a reader

Latest Comments

 

Holy Cannoli

New bakery opens in Ben Lomond, plus Randall Grahm’s quest to grow 10,000 new grape varieties, and Mexican cooking classes

 

Is Santa Cruz turning into Malibu North?

It's got a ways to go before it gets wrecked like Malibu, but I think we need to be very careful about growth. Maria Mattioli, Santa Cruz, Psychotherapist

 

Bargetto Winery

A much-anticipated annual event at Bargetto Winery is the release of their very special La Vita red wine. June 7 was the day to be heralded this year, and I happily squeezed my car into their overloaded car park in eager anticipation of tasting the new La Vita nectar.

 

Margaritaville

Popular Capitola spot gets new owner and complete makeover